Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring
Weiye Yu(Shenzhen Nanshan Center for Chronic Disease Control), Yì Wáng(Shanghai Medical College of Fudan University), Aliaksandr Skrahin(Belarusian State Medical University), Majid Assadi, Andrei Gabrielian(National Institutes of Health), Xi-Ling Huang(Chinese University of Hong Kong), Michael Tartakovsky(National Institutes of Health), Pu-Xuan Lu(Shenzhen Nanshan Center for Chronic Disease Control), Alex Rosenthal(National Institutes of Health)
Cited by 62
Related Papers
Multifunctional biohybrid magnetite microrobots for imaging-guided therapy
|Science Robotics|2017|873
DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics
|Nucleic Acids Research|2020|667
DBAASP v.2: an enhanced database of structure and antimicrobial/cytotoxic activity of natural and synthetic peptides
|Nucleic Acids Research|2015|241
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
|Science Translational Medicine|2014|158
The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis
|Journal of Clinical Microbiology|2017|140